NO20071618L - Fremgangsmate for screening av antistoffbibliotek - Google Patents

Fremgangsmate for screening av antistoffbibliotek

Info

Publication number
NO20071618L
NO20071618L NO20071618A NO20071618A NO20071618L NO 20071618 L NO20071618 L NO 20071618L NO 20071618 A NO20071618 A NO 20071618A NO 20071618 A NO20071618 A NO 20071618A NO 20071618 L NO20071618 L NO 20071618L
Authority
NO
Norway
Prior art keywords
target groups
members
library
antibody library
screening antibody
Prior art date
Application number
NO20071618A
Other languages
English (en)
Norwegian (no)
Inventor
Marike Josee Janneke G Stassar
Herald Reiersen
Original Assignee
Affitech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affitech As filed Critical Affitech As
Publication of NO20071618L publication Critical patent/NO20071618L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Lasers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20071618A 2004-10-08 2007-03-27 Fremgangsmate for screening av antistoffbibliotek NO20071618L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0422431.7A GB0422431D0 (en) 2004-10-08 2004-10-08 Method
PCT/GB2005/003866 WO2006038022A1 (en) 2004-10-08 2005-10-07 Methods for antibody library screening

Publications (1)

Publication Number Publication Date
NO20071618L true NO20071618L (no) 2007-06-27

Family

ID=33443626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071618A NO20071618L (no) 2004-10-08 2007-03-27 Fremgangsmate for screening av antistoffbibliotek

Country Status (21)

Country Link
US (1) US20090081190A1 (pt)
EP (1) EP1800133B1 (pt)
JP (1) JP4564062B2 (pt)
CN (1) CN101052879B (pt)
AT (1) ATE495446T1 (pt)
AU (1) AU2005291012B2 (pt)
BR (1) BRPI0516546A (pt)
CA (1) CA2580080C (pt)
DE (1) DE602005025901D1 (pt)
DK (1) DK1800133T3 (pt)
ES (1) ES2359724T3 (pt)
GB (1) GB0422431D0 (pt)
HR (1) HRP20110234T1 (pt)
IL (1) IL181927A (pt)
NO (1) NO20071618L (pt)
NZ (1) NZ554076A (pt)
PL (1) PL1800133T3 (pt)
RU (1) RU2402777C2 (pt)
SI (1) SI1800133T1 (pt)
WO (1) WO2006038022A1 (pt)
ZA (1) ZA200702527B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009032949A2 (en) * 2007-09-04 2009-03-12 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
US9079942B2 (en) * 2009-02-09 2015-07-14 Epitomics, Inc. CDR-anchored amplification method
US20100317539A1 (en) * 2009-06-12 2010-12-16 Guo-Liang Yu Library of Engineered-Antibody Producing Cells
US8293483B2 (en) * 2009-09-11 2012-10-23 Epitomics, Inc. Method for identifying lineage-related antibodies
US9340606B2 (en) 2010-10-26 2016-05-17 Arizona Board Of Regents On Behalf Of Arizona State University Immunization with amyloid-beta oligomers
GB201116364D0 (en) * 2011-09-22 2011-11-02 Bioinvent Int Ab Screening methods and uses thereof
ES3011307T3 (en) * 2012-02-23 2025-04-07 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
EP2786147B1 (en) * 2012-12-04 2017-02-01 Scinopharm Taiwan Ltd. Method for selecting a pool of molecules
RU2560699C2 (ru) * 2013-08-02 2015-08-20 федеральное государственное автономное образовательное учреждение высшего профессионального образования "Национальный исследовательский ядерный университет МИФИ" (НИЯУ МИФИ) Способ создания наноразмерной диагностической метки на основе конъюгатов наночастиц и однодоменных антител
GB201420852D0 (en) * 2014-11-24 2015-01-07 Genevillage Kft Method
RU2618872C1 (ru) * 2015-12-09 2017-05-11 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ направленного истощения олигонуклеотидных библиотек для снижения неспецифической адсорбции при твердофазной селекции аптамеров на основе нуклеиновых кислот
US10557216B2 (en) * 2018-04-24 2020-02-11 Inscripta, Inc. Automated instrumentation for production of T-cell receptor peptide libraries
BR112021021261A2 (pt) 2019-04-22 2021-12-21 Ddbio Co Ltd Shang Hai Método para produzir uma biblioteca de fagos que exibe um anticorpo ou fragmento de anticorpo, biblioteca de fagos e método para selecionar um anticorpo ou fragmento de anticorpo
KR102301987B1 (ko) * 2019-11-14 2021-09-13 연세대학교 산학협력단 항체 선별 방법, 박테리아 오염 진단 방법 및 박테리아 오염 진단 키트

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5492807A (en) * 1993-11-19 1996-02-20 Santi; Daniel V. Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease
US6255455B1 (en) * 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
TW585921B (en) * 1997-07-10 2004-05-01 Res Dev Foundation Species specific monoclonal antibodies and phage displayed Fab and scFV fragments for fragments for targeted destruction of imported fire ants
RU2184780C2 (ru) * 2000-08-09 2002-07-10 Государственный научный центр вирусологии и биотехнологии "Вектор" ПЕПТИД-ИМИТАТОР ЭПИТОПА БЕЛКА gp120 ВИЧ-1
US6235686B1 (en) * 2000-08-16 2001-05-22 R.T. Vanderbilt Company, Inc. Lubricating compositions containing aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers
EP2028187A1 (en) * 2000-09-08 2009-02-25 Board Of Regents, The University Of Texas System Human and mouse targeting peptides identified by phage display
US7420030B2 (en) * 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20040170955A1 (en) * 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting

Also Published As

Publication number Publication date
HK1105450A1 (en) 2008-02-15
CA2580080A1 (en) 2006-04-13
DK1800133T3 (da) 2011-03-28
DE602005025901D1 (de) 2011-02-24
BRPI0516546A (pt) 2008-09-09
JP2008516220A (ja) 2008-05-15
HRP20110234T1 (hr) 2011-05-31
RU2402777C2 (ru) 2010-10-27
ATE495446T1 (de) 2011-01-15
GB0422431D0 (en) 2004-11-10
EP1800133A1 (en) 2007-06-27
CN101052879B (zh) 2012-07-25
JP4564062B2 (ja) 2010-10-20
CA2580080C (en) 2012-09-18
ES2359724T3 (es) 2011-05-26
WO2006038022A1 (en) 2006-04-13
NZ554076A (en) 2009-12-24
AU2005291012A1 (en) 2006-04-13
RU2007117144A (ru) 2008-11-20
IL181927A (en) 2011-09-27
SI1800133T1 (sl) 2011-06-30
IL181927A0 (en) 2007-07-04
ZA200702527B (en) 2008-11-26
AU2005291012B2 (en) 2011-04-14
EP1800133B1 (en) 2011-01-12
CN101052879A (zh) 2007-10-10
US20090081190A1 (en) 2009-03-26
PL1800133T3 (pl) 2011-06-30

Similar Documents

Publication Publication Date Title
NO20071618L (no) Fremgangsmate for screening av antistoffbibliotek
Cho et al. Application of saturates, aromatics, resins, and asphaltenes crude oil fractionation for detailed chemical characterization of heavy crude oils by Fourier transform ion cyclotron resonance mass spectrometry equipped with atmospheric pressure photoionization
Nesper et al. A novel capture compound for the identification and analysis of cyclic di-GMP binding proteins
Carrasco-Pancorbo et al. Gas chromatography/atmospheric pressure chemical ionization-time of flight mass spectrometry: analytical validation and applicability to metabolic profiling
O’Connell et al. Solution-Based Indirect Affinity Selection Mass Spectrometry A General Tool For High-Throughput Screening Of Pharmaceutical Compound Libraries
WO2010119261A8 (en) Method for quantifying modified peptides
NZ584684A (en) A method for characterization of a recombinant polyclonal protein
Becker et al. Rapid and simultaneous analysis of three molecular sea surface temperature proxies and application to sediments from the Sea of Marmara
Dayon et al. Proteomics of human plasma: A critical comparison of analytical workflows in terms of effort, throughput and outcome
Ning et al. A charge-suppressing strategy for probing protein methylation
Kovalchik et al. Standard method design considerations for semi-quantification of total naphthenic acids in oil sands process affected water by mass spectrometry: A review
WO2021222910A3 (en) Instant early stage disease detection by decoding organic compound signatures
EP4675278A3 (en) Assay for plasma cell associated disease
Patrick et al. Differentiating sulfopeptide and phosphopeptide ions via resonant infrared photodissociation
Battistini et al. Proteomic analysis by mass spectrometry of postmortem muscle protein degradation for PMI estimation: A pilot study
Neumann et al. Automated LC-HRMS (/MS) approach for the annotation of fragment ions derived from stable isotope labeling-assisted untargeted metabolomics
NO20075285L (no) Fremgangsmate for a bestemme og kontrollere dannelsen av avsetninger i et vannsystem
WO2009011426A1 (ja) γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法
Jeannot et al. Advancing PFASs monitoring in food: from targeted SPE-LC-MS/MS to non-targeted QuEChERS-LC-HRMS approaches
Lee et al. Impact of Protonation Sites on Collision-Induced Dissociation-MS/MS Using CIDMD Quantum Chemistry Modeling
Asada et al. Isomeric discrimination of synthetic cannabinoids by GC‐EI‐MS: 1‐adamantyl and 2‐adamantyl isomers of N‐adamantyl carboxamides
Boatto et al. Determination of four thiophenethylamine designer drugs (2C-T-series) in human plasma by capillary electrophoresis with mass spectrometry detection
Pai et al. Direct glycan structure determination of intact N-linked glycopeptides by low-energy collision-induced dissociation tandem mass spectrometry and predicted spectral library searching
Bischoff et al. Genomic variability and protein species—Improving sequence coverage for proteogenomics
CN105241946B (zh) 一种分析石油中硫醇化合物分子组成的方法

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application